Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 80 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2008Fatigue in non-alcoholic fatty liver disease (NAFLD) is significant and associates with inactivity and excessive daytime sleepiness but not with liver diseaseNewton, J.; Jones, D.; Henderson, E.; Kane, L.; Wilton, K.; Burt, A.; Day, C.
2008Mortality and length-of-stay outcomes, 1993-2003, in the binational Australian and New Zealand intensive care adult patient databaseMoran, J.; Bristow, P.; Solomon, P.; George, C.; Hatt, G.
2008Bone density and fracture riskNordin, B.; Prince, R.; Tucker, G.
2008Qualities men value when communicating with general practitioners: implications for primary care settingsSmith, J.; Braunack-Mayer, A.; Wittert, G.; Warin, M.
2008Orbital Arteriovenous MalformationsWarrier, S.; Prabhakaran, V.; Valenzuela, A.; Sullivan, T.; Davis, G.; Selva-Nayagam, D.
2008Energy expenditure, satiety, and plasma ghrelin, glucagon-like peptide 1, and peptide tyrosine-tyrosine concentrations following a single high -protein launchSmeets, A.; Soenen, S.; Luscombe-Marsh, N.; Ueland, O.; Westerterp-Plantenga, M.
2008Variability of QT interval duration in obstructive sleep apnea: An indicator of disease severityBaumert, M.; Smith, J.; Catcheside, P.; McEvoy, R.; Abbott, D.; Sanders, P.; Nalivaiko, E.
2008Comparative effects of intraduodenal infusions of lauric and oleic acids on antropyloroduodenal motility, plasma cholecystokinin and peptide YY, appetite, and energy intake in healthy menFeltrin, K.; Little, T.; Meyer, J.; Horowitz, M.; Rades, T.; Wishart, J.; Feinle-Bisset, C.
2008Molecular, pathologic, and clinical features of early-onset endometrial cancer: identifying presumptive Lynch syndrome patientsWalsh, M.; Cummings, M.; Buchanan, D.; Dambacher, W.; Arnold, S.; McKeone, D.; Byrnes, R.; Barker, M.; Leggett, B.; Gattas, M.; Jass, J.; Spurdle, A.; Young, J.; Obermair, A.
2008Ethnicity and risk for colorectal cancers showing somatic BRAF V600E mutation or CpG island methylator phenotypeEnglish, D.; Young, J.; Simpson, J.; Jenkins, M.; Southey, M.; Walsh, M.; Buchanan, D.; Barker, M.; Haydon, A.; Royce, S.; Roberts, A.; Parry, S.; Hopper, J.; Jass, J.; Giles, G.